[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 23, 2011 (June 20, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 _____________________________ see Item 5.07 Submission]
[Global Sources Press Contact in Asia: Global Sources Investor Contact in Asia: Camellia So Suzanne Wang Tel: (852) 2555-5021 Tel: (852) 2555-4747 cso@globalsources.com e-mail: investor@globalsources.com e-mail: Global Sources Press Contact in U.S.: Global Sources Investor Contact in U.S.: James W.W. Strachan Mary Magnani & Timothy Dien Tel: (1 480) 664 8309 Lippert/Heilshorn & Associates, Inc. strachan@globalsources.com e-mail: Tel: (1 415)]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 23, 2011 (June 20, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 _____________________________ see Item 5.07 Submission]
[+86 (536) 567-0008 o o o o Item 5.07 Submission of Matters to a Vote of Security Holders. On June 22, 2011, Gulf Resources, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) to vote on the following matters: 1. Election of Directors All of the following seven nominees were elected to the Company’s Board of Directors,]
[+86 (536) 567-0008 o o o o Item 5.07 Submission of Matters to a Vote of Security Holders. On June 22, 2011, Gulf Resources, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) to vote on the following matters: 1. Election of Directors All of the following seven nominees were elected to the Company’s Board of Directors,]
[Page of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI)mpany Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands]
[Page of Pages CUSIP No.G21107100HEDULE 13D/A 1 NAME OF REPORTING PERSON Golden Meditech Stem Cells (BVI)mpany Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands]
[Prospectus Supplement (to Prospectusted May19, 2011) Registration No.333-174341 HOME INNS & HOTELS MANAGEMENT $184,000,000gregate Principal Amount of 7,200,382 American Depositary Shares Representing Investing in the Notes involves significant risks. See Risk Factors beginning on page 10 of the prospectus. Thete of this prospectus supplement is June23, 2011.]
